When was IMMUNO-CELL INTERNATIONAL founded?

IMMUNO-CELL INTERNATIONAL was founded on 01 Aug 1994, making it 32 years old.

Is IMMUNO-CELL INTERNATIONAL still active?

Yes, IMMUNO-CELL INTERNATIONAL is currently active.

Where is IMMUNO-CELL INTERNATIONAL registered?

IMMUNO-CELL INTERNATIONAL's registered address is Motstraat 72 box 8, 2800 Mechelen, Belgium.

How many employees does IMMUNO-CELL INTERNATIONAL have?

Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2025), IMMUNO-CELL INTERNATIONAL reported 6.5 full-time equivalent employees.

Did IMMUNO-CELL INTERNATIONAL make a profit or a loss?

IMMUNO-CELL INTERNATIONAL's most recently filed annual accounts (fiscal year ending 31 Dec 2025) reported a profit of €478,283.

When did IMMUNO-CELL INTERNATIONAL last file annual accounts?

IMMUNO-CELL INTERNATIONAL's most recently filed annual accounts cover the fiscal year ending 31 Dec 2025.

Is IMMUNO-CELL INTERNATIONAL B Corp certified?

We have no B Corp certification on file for IMMUNO-CELL INTERNATIONAL.

Does IMMUNO-CELL INTERNATIONAL hold Fairtrade certification?

No, IMMUNO-CELL INTERNATIONAL does not currently hold Fairtrade certification.

IMMUNO-CELL INTERNATIONAL

Q: What does IMMUNO-CELL INTERNATIONAL do?

IMMUNO-CELL INTERNATIONAL's registered main activities are Manufacture of hollow glass, Other printing, Wholesale of pharmaceutical and medical goods, Reproduction: production typographical forms, offset print reproduction and printing plates, rotogravure cylinders and reproduction, and Wholesale trade of medical, surgical and dental supplies. It is also registered for 1 additional activity.

BE 0453.361.865

Copied!

BV/SRL

Status

Active

Founded

01 Aug 1994

Size

Micro · 6.5 FTE

Age

32 yrs

Main activity

Manufacture of hollow glass

Website

immuno-cell.com

Activities

6 activities

Manufacture of hollow glassOther printingWholesale of pharmaceutical and medical goodsReproduction: production typographical forms, offset print reproduction and printing plates, rotogravure cylinders and reproductionWholesale trade of medical, surgical and dental suppliesRetail sale of other new goods n.e.c.

Financials

Profit / Loss2025

€478K-8.3%

Equity2025

€955K+45.4%

Cash2025

€191K+3.3%

2025	2024	2023	2022
€478,283-8.3%	€521,820+2.2%	€510,617-9.4%	€563,640
€955,309+45.4%	€657,026+35.4%	€485,206+2.2%	€474,589
€604,085+6.4%	€567,909-52.3%	€1,189,580-31.9%	€1,745,939
€191,362+3.3%	€185,247-71%	€639,270-1.5%	€649,283
6.5-11%	7.3+2.8%	7.1+29.1%	5.5

Frequently asked questions

01What is IMMUNO-CELL INTERNATIONAL's official registered name?

IMMUNO-CELL INTERNATIONAL.

02What is IMMUNO-CELL INTERNATIONAL's enterprise number (VAT number)?

BE 0453.361.865.

03What is IMMUNO-CELL INTERNATIONAL's legal form?

Besloten Vennootschap (BV) / Société à responsabilité limitée (SRL).

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

Financial statements

	2025	2024	2023	2022
Income statement
	6.5-11%	7.3+2.8%	7.1+29.1%	5.5
	€975,426-11.8%	€1,106,170+5.8%	€1,045,894-4.8%	€1,099,145
	€242,988-26.9%	€332,564+8%	€307,912+23.8%	€248,653
	€100,235+449.2%	€18,250-59.8%	€45,415-34.9%	€69,800
	€654,920-4.2%	€683,330+5.1%	€650,481-15.6%	€771,014
	€478,283-8.3%	€521,820+2.2%	€510,617-9.4%	€563,640
	€3,998	—	—	—
Profitability
	50.1%-37%	79.4%-24.5%	105.2%-11.4%	118.8%
	30.7%-28%	42.6%+39.7%	30.5%+20.1%	25.4%
Solvency
	€1,559,394+27.3%	€1,224,934-26.9%	€1,674,785-24.6%	€2,220,528
	€199,919+15.2%	€173,560-28.3%	€242,239-14.1%	€282,032
	€19,611+55.5%	€12,6110%	€12,611+10.6%	€11,400
	€955,309+45.4%	€657,026+35.4%	€485,206+2.2%	€474,589
	61.3%+14.2%	53.6%+85.1%	29.0%+35.6%	21.4%
	€103,344+42.2%	€72,659-33.5%	€109,238-24.8%	€145,273
	0.11-2.2%	0.11-50.9%	0.23-26.4%	0.31
	€604,085+6.4%	€567,909-52.3%	€1,189,580-31.9%	€1,745,939
	0.63-26.8%	0.86-64.7%	2.45-33.4%	3.68
Liquidity
	€191,362+3.3%	€185,247-71%	€639,270-1.5%	€649,283
	€392,987+10%	€357,252+38%	€258,841-3.5%	€268,169
	€356,421+7.6%	€331,378-25.5%	€444,991+13.7%	€391,290
	€138,394+79.5%	€77,081-81.7%	€420,632-28.8%	€590,403
	€500,314+1%	€495,250-54%	€1,075,840-32.8%	€1,600,666
	1.96+14.8%	1.71+136.1%	0.72-9.4%	0.80
	€671,137+25.4%	€535,053+57.6%	€339,594+4.2%	€326,032
Profit appropriation
	€180,000-48.6%	€350,000-30%	€500,000-47.4%	€950,000
	€253,0720%	€253,0720%	€253,0720%	€253,072
	€652,236+84.3%	€353,953+94.3%	€182,134+6.2%	€171,517

Sources

NBB — Nationale Bank van België

IMMUNO-CELL INTERNATIONAL

Activities

Financials

Frequently asked questions

All locations

Financial statements

All locations

Financial statements